Cost-effectiveness of canakinumab to prevent recurrent cardiovascular events

被引：0
|
作者：
Sehested, T. S. G. [1 ]
Bjerre, J. [2 ]
Chang, A. [3 ]
Ku, S. [4 ]
Jahansouz, A. [5 ]
Owens, D. K. [6 ,7 ]
Hlatky, M. A. [8 ]
Goldhaber-Fiebert, J. D. [6 ,7 ]
机构：
[1] Danish Heart Fdn, Dept Cardiovasc Epidemiol & Res, Copenhagen, Denmark
[2] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark
[3] Stanford Univ, Med Ctr, Dept Med, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Stanford, CA USA
[5] Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA
[6] Stanford Univ, Ctr Hlth Policy & Primary Care, Stanford, CA 94305 USA
[7] Stanford Univ, Ctr Outcomes Res, Stanford, CA 94305 USA
[8] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA
来源：
EUROPEAN HEART JOURNAL | 2018年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2562
引用
收藏
页码：503 / 504
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events
    Sehested, Thomas S. G.
    Bjerre, Jenny
    Ku, Seul
    Chang, Andrew
    Jahansouz, Alison
    Owens, Douglas K.
    Hlatky, Mark A.
    Goldhaber-Fiebert, Jeremy D.
    JAMA CARDIOLOGY, 2019, 4 (02) : 128 - 135
  • [2] Cost-Effectiveness of Canakinumab From a Canadian Perspective for Recurrent Cardiovascular Events
    Boczar, Kevin E.
    Beanlands, Rob
    Wells, George
    Coyle, Doug
    CJC OPEN, 2022, 4 (05) : 441 - 448
  • [3] Cost-Effectiveness of Colchicine for Recurrent Cardiovascular Events
    Boczar, Kevin E.
    Beanlands, Rob
    Wells, George
    Coyle, Doug
    CJC OPEN, 2023, 5 (05) : 348 - 356
  • [4] Cost-effectiveness of a text message programme for the prevention of recurrent cardiovascular events
    Burn, Edward
    Nghiem, Son
    Jan, Stephen
    Redfern, Julie
    Rodgers, Anthony
    Thiagalingam, Aravinda
    Graves, Nicholas
    Chow, Clara K.
    HEART, 2017, 103 (12) : 923 - U57
  • [5] Cost-effectiveness of workplace wellness to prevent cardiovascular events among US firefighters
    Patterson, P. Daniel
    Smith, Kenneth J.
    Hostler, David
    BMC CARDIOVASCULAR DISORDERS, 2016, 16
  • [6] Cost-effectiveness of smoking cessation therapy compared with statins to prevent cardiovascular events
    Beck, CR
    Yeo, WW
    Yeo, KR
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (05) : 689 - 689
  • [7] Ticagrelor for acute coronary disease to prevent cardiovascular events: Cost-effectiveness analysis in Indonesia
    At Thobari, Jarir
    Haposan, Jonathan Hasian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 418 - 418
  • [8] The cost-effectiveness of canakinumab for secondary prevention of cardiovascular disease: The Australian healthcare perspective
    Zomer, Ella
    Liew, Danny
    Tonkin, Andrew
    Trauer, James M.
    Ademi, Zanfina
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 285 : 1 - 5
  • [9] Cost-effectiveness of workplace wellness to prevent cardiovascular events among U.S. firefighters
    P. Daniel Patterson
    Kenneth J. Smith
    David Hostler
    BMC Cardiovascular Disorders, 16
  • [10] COST-EFFECTIVENESS OF ICOSAPENT ETHYL FOR PREVENTING CARDIOVASCULAR EVENTS
    Dressel, A.
    ATHEROSCLEROSIS, 2023, 379
12345